Rosty Raykov
CHIEF EXECUTIVE OFFICER at Fennec Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Fennec Pharmaceuticals Inc., 3 years.
Fennec Pharmaceuticals Inc.
Director · CHIEF EXECUTIVE OFFICER
Chief executive roles
Fennec Pharmaceuticals Inc.
· CHIEF EXECUTIVE OFFICER
Until August 2024
· Former
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Fennec Pharmaceuticals Inc. | Open-market sale | −10,000 | $9.58 | $95,800 |
| Jul 31, 2026 | Fennec Pharmaceuticals Inc. | Grant or award | +2,778 | — | — |
| Jul 1, 2026 | Fennec Pharmaceuticals Inc. | Grant or award | +2,778 | — | — |
| Jul 1, 2026 | Fennec Pharmaceuticals Inc. | Option exercise | +15,597 | $2.45 | $38,213 |
| Jul 1, 2026 | Fennec Pharmaceuticals Inc. | Open-market sale | −9,599 | $10.41 | $99,926 |
| Jun 1, 2026 | Fennec Pharmaceuticals Inc. | Option exercise | +15,597 | $2.45 | $38,213 |
| Jun 1, 2026 | Fennec Pharmaceuticals Inc. | Open-market sale | −9,747 | $9.62 | $93,766 |
| May 31, 2026 | Fennec Pharmaceuticals Inc. | Grant or award | +2,778 | — | — |
| May 1, 2026 | Fennec Pharmaceuticals Inc. | Option exercise | +15,598 | $2.45 | $38,215 |
| May 1, 2026 | Fennec Pharmaceuticals Inc. | Open-market sale | −10,781 | $6.47 | $69,753 |
| Apr 30, 2026 | Fennec Pharmaceuticals Inc. | Option exercise | +2,778 | — | — |
| Apr 1, 2026 | Fennec Pharmaceuticals Inc. | Option exercise | +15,598 | $2.45 | $38,215 |
| Apr 1, 2026 | Fennec Pharmaceuticals Inc. | Open-market sale | −10,946 | $6.31 | $69,069 |
| Mar 31, 2026 | Fennec Pharmaceuticals Inc. | Grant or award | +5,208 | — | — |
| Mar 2, 2026 | Fennec Pharmaceuticals Inc. | Option exercise | +15,598 | $2.45 | $38,215 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.